Enhancement of sodium butyrate-induced cell death and apoptosis by X-irradiation in the human colorectal cancer cell line HCT 116

Oncology Reports

Volumn 20, Issue 2, 2008, Pages 397-403

  Wei, Zheng Li ^a   Zhao, Qing Li ^a   Yu, Da Yong ^a   Hassan, Mariame A ^a   Nomura, Takaharu ^b   Kondo, Takashi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b CENTRAL RESEARCH INSTITUTE OF ELECTRIC POWER INDUSTRY   (Japan)

Author keywords

Apoptosis; Cell death; HCT 116 colorectal cancer cells; Radiation; Sodium butyrate

Indexed keywords

BUTYRIC ACID; CASPASE 3; CASPASE 8; CYTOCHROME C; DEATH RECEPTOR; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; SUPEROXIDE;

APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CELL CYCLE ARREST; CELL DEATH; CELL PROLIFERATION; CELL STRAIN HCT116; COLORECTAL CANCER; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TUMOR SUPPRESSOR GENE; WILD TYPE; X IRRADIATION;

APOPTOSIS; BUTYRATES; CASPASES; CELL CYCLE; CELL PROLIFERATION; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; ENZYME INHIBITORS; FLOW CYTOMETRY; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPEROXIDES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; X-RAYS;

EID: 48749114296     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or_00000021     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics. CA Cancer J Clin 57: 43-66, 2007.
2. Chau I and Cunningham D: Chemotherapy in colorectal cancer: new options and new challenges. Br Med Bull 64: 159-180, 2002.
3. Wolpin BM, Meyerhardt JA, Mamon HJ and Mayer RJ: Adjuvant treatment of colorectal cancer. CA Cancer J Clin 57: 168-185, 2007.
4. Chopin V, Toillon RA, Jouy N and Le Bourhis X: Sodium butyrate induces P53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells. Br J Pharmacol 135: 79-86, 2002.
5. Sengupta S, Muir JG and Gibson PR: Does butyrate protect from colorectal cancer? J Gastroenterol Hepatol 21: 209-218, 2006.
6. Kelly WK, O'Connor OA and Marks PA: Histone deacetylase inhibitors: from target to clinical trials. Expert Opin Investig Drugs 11: 1695-1713, 2002.
7. Arundel CM, Glicksman AS and Leith JT: Enhancement of radiation injury in human colon tumor cells by the maturational agent sodium butyrate (NaB). Radiat Res 104: 443-448, 1985.
8. Leith JT, Hallows KT, Arundel CM and Bliven SF: Changes in X-ray sensitivity and glutathione content of human colon tumor cells after exposure to the differentiation-inducing agent sodium butyrate. Radiat Res 114: 579-588, 1988.
9. Stoilov L, Darroudi F, Meschini R, van der Schans G, Mullenders LH and Natarajan AT: Inhibition of repair of X-ray-induced DNA double-strand breaks in human lymphocytes exposed to sodium butyrate. Int J Radiat Biol 76: 1485-1491, 2000.
10. Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D and Paraskeva C: Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer 55: 498-505, 1993.
11. Hunter A, Hendrikse A, Renan M and Abratt R: Does the tumor microenvironment influence X-irradiation-induced apoptosis? Apoptosis 11: 1727-1735, 2006.
12. Patterson MK Jr: Measurement of growth and viability of cells in culture. Methods Enzymol 58: 141-152, 1979.
13. Sellins KS and Cohen JJ: Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 139: 3199-3206, 1987.
14. Hopcia KL, McCarey YL, Sylvester FC and Held KD: X-irradiation-induced apoptosis in HL60 cells: oxygen effect, relationship between apoptosis and loss of clonogenicity, and dependence of time to apoptosis on radiation dose. Radiat Res 145: 315-323, 1996.
15. Petronilli V, Penzo D, Scorrano L, Bernardi P and Di Lisa F: The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ. J Biol Chem 276: 12030-12034, 2001.
16. Gorman AM, Heavey B, Creagh E, Cotter TG and Samali A: Antioxidant-mediated inhibition of the heat shock response leads to apoptosis. FEBS Lett 445: 98-102, 1999.
17. Zhao QL, Kondo T, Noda A and Fujiwara Y: Mitochondrial and intracellular free-calcium regulation of X-irradiation-induced apoptosis in human leukemic cells. Int J Radiat Biol 75: 493-504, 1999.
18. Zhao QL, Fujiwara Y and Kondo T: Mechanism of cell death induction by nitroxide and hyperthermia. Free Radic Biol Med 40: 1131-1143, 2006.
19. Danial NN and Korsmeyer SJ: Cell death: critical control points. Cell 116: 205-219, 2004.
20. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and Korsmeyer SJ: Proapoptotic Bax and Bak: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730, 2001.
21. Yin XM: Bid, a BH3-only multi-functional molecule, is at the cross road of life and death. Gene 369: 7-19, 2006.
22. Antonsson B, Conti F, Ciavatta A, Montessuit S, Lewis S, Martinou I, Bernasconi L, Bernard A, Mermod JJ, Mazzei G, Maundrell K, Gambale F, Sadoul R and Martinou JC: Inhibition of Bax channel-forming activity by Bcl-2. Science 277: 370-372, 1997.
23. Yang E, Zha J, Jockel J, Boise LH, Thompson CB and Korsmeyer SJ: Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell 80: 285-291, 1995.
24. Sattler M, Liang H, Nettesheim D, Meadows RP, Harlan JE, Eberstadt M, Yoon HS, Shuker SB, Chang BS, Minn AJ, Thompson CB and Fesik SW: Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 275: 983-986, 1997.
25. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P and Moll UM: p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11: 577-590, 2003.
26. Pearson AS, Spitz FR, Swisher SG, Kataoka M, Sarkiss MG, Meyn RE, McDonnell TJ, Cristiano RJ and Roth JA: Upregulation of the proapoptotic mediators Bax and Bak after adenovirus-mediated p53 gene transfer in lung cancer cells. Clin Cancer Res 6: 887-890, 2000.
27. Waldman T, Kinzler KW and Vogelstein B: p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 55: 5187-5190, 1995.
28. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B: Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501, 1998.
29. Hinnebusch BE, Meng S, Wu JT, Archer SY and Hodin RA: The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 132: 1012-1017, 2002.
30. Cayrol C, Knibiehler M and Ducommun B: p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene 16: 311-320, 1998.
31. Chakraborti T, Das S, Mondal M, Roychoudhury S and Chakraborti S: Oxidant, mitochondria and calcium: an overview. Cell Signal 11: 77-85, 1999.